Skip to search formSkip to main contentSkip to account menu

Antihemophilic Factor, Human Recombinant 1 UNT Injection [Recombinate]

Known as: ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 2000 [iU] in 5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [RECOMBINATE], ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 1000 [iU] in 5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [RECOMBINATE], ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 25 [iU] in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Recombinate] 
National Institutes of Health

Related topics

Related topics

13 relations
Albumin Human, USPAntihemophilic Factor, Human RecombinantCalciumHistidine

Broader (1)

Antihemophilic Factor, Human Recombinant 1 UNT Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Alergenele recombinate – metode de producere şi utilitatea în diagnosticul molecular şi în imunoterapia alergenică
Although allergen extracts show some disadvantages, they are widely used both for in vivo diagnosis and for allergen… 
2000
2000
Transient Inhibitors in the Recombinate Pup Study
1. Nazarenko IA, Bhatnagar SK, Hohman RJ. A closed tube format for amplification and detection of DNA based on energy transfer… 
1995
1995
Report on Experiences with Two Recombinant Factor VIII Concentrates: Kogenate® (Bayer) and Recombinate® (Baxter)
Seit kurzer Zeit sind zwei rekombinante Faktor-VIII-Konzentrate, Kogenate® (Bayer) und Recombinate® (Baxter), zur Behandlung von… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)